|Bid||131.73 x 4000|
|Ask||132.09 x 800|
|Day's Range||127.66 - 132.11|
|52 Week Range||69.60 - 146.95|
|Beta (5Y Monthly)||1.54|
|PE Ratio (TTM)||297.92|
|Earnings Date||Oct 26, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||0.80 (0.56%)|
|Ex-Dividend Date||Jun 14, 2021|
|1y Target Est||159.20|
Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.
LARGO, Fla., September 07, 2021--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the 19th Annual Morgan Stanley Global Healthcare Conference at 5:00 p.m. ET on Tuesday, September 14, 2021.
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.